CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

NanoStat

nanobio

Ann Arbor Firm’s Technology Makes Vaccines More Effective

NanoBio Corp. Tuesday said that it is presenting new data demonstrating positive pre-clinical results for its intramuscular respiratory syncytial virus vaccine at the National Foundation for Infectious Diseases 16th Annual Conference on Vaccine Research.

WWJ Newsradio 950–04/23/2013

nanobio

NanoBio’s Intranasal Vaccine Induces Robust Immunity in Animals

NanoBio Corp. announced Wednesday that data from recent animal studies of its NanoStat-based intranasal respiratory syncytial virus vaccine have shown strong immunity effects, paving the way for more studies of the nanoparticle-based technology.

WWJ Newsradio 950–08/24/2011

Follow

Get every new post delivered to your Inbox.

Join 1,881 other followers